36 results on '"Colak, Seda"'
Search Results
2. Assessment of venous disease with different venous disease specific scales in Behçet’s disease patients with deep vein thrombosis
3. Predictors for the risk and severity of post-thrombotic syndrome in vascular Behçet's disease
4. Physiciansʼ Biological Drug Preference in Patients With Rheumatoid Arthritis and Spondyloarthritis With a History of Malignancy: Perspectives From the Treasure Database
5. The Risk of Presarcopenia Is Increased Among Female Patients With Primary Sjögren’s Syndrome
6. The relationship between bristol rheumatoid arthritis fatigue scales and disease activity of patients with rheumatoid arthritis
7. Age-Related Differences in the Clinical Phenotypes of Behçet's Disease: The Experience of Two Referral Centers
8. Determination of serum vascular endothelial growth factor (VEGF) and VEGF receptor levels with VEGF gene polymorphisms in patients with Behçet’s uveitis
9. Physicians' Biological Drug Preference in Patients With Rheumatoid Arthritis and Spondyloarthritis With a History of Malignancy
10. The Risk of Presarcopenia Is Increased Among Female Patients With Primary Sjögren’s Syndrome
11. COVID-19 Among Patients With Inflammatory Rheumatic Diseases
12. Determination of serum vascular endothelial growth factor (VEGF) and VEGF receptor levels with VEGF gene polymorphisms in patients with Behçet's uveitis.
13. Sarcopenia in rheumatoid arthritis: Is it a common manifestation?
14. The assessment of tocilizumab therapy on recurrent attacks of patients with familial Mediterranean fever: A retrospective study of 15 patients
15. An investigation of thiol/disulfide homeostasis in patients with Behçet’s disease
16. Serum neopterin and ischemia modified albumin levels are associated with the disease activity of adult immunoglobulin A vasculitis (Henoch‐Schönlein purpura)
17. AB0605 SERUM NEOPTERIN AND ISCHEMIA MODIFIED ALBUMIN LEVELS ARE ASSOCIATED WITH THE DISEASE ACTIVITY OF ADULT IMMUNOGLOBULIN A VASCULITIS (HENOCH-SCHONLEIN PURPURA)
18. FRI0586 THE EFFECT OF TOCILIZUMAB IN THE PREVENTION OF FAMILIAL MEDITERRANEAN FEVER ATTACKS
19. FRI0615 EVALUATION OF COMPLIANCE AND RELATED FACTORS IN COLCHICINE TREATMENT IN FAMILIAL MEDITERRANEAN FEVER PATIENTS
20. AB0573 ASSESSMENT OF PRESENCE, SEVERITY AND RISK FACTORS OF POST- THROMBOTIC SYNDROME IN VASCULAR BEHÇET DISEASE: MUTICENTERED RETROSPECTIVE STUDY
21. THU0587 COMPARING OF TWO DISTINCT SEVERITY SCORES FOR EVALUATING DISEASE SEVERITY IN FAMILIAL MEDITERRANEAN FEVER
22. AB1107 COMPLEMENTARY AND ALTERNATIVE MEDICINE USAGE IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER
23. An evaluation of depression, anxiety and fatigue in patients with Behçet’s disease
24. COVID-19 Among Patients With Inflammatory Rheumatic Diseases.
25. The relationship of serum VEGF and sVEGFR-1 levels with vascular involvement in patients with Behçet's disease
26. Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behçet’s disease
27. An evaluation of depression, anxiety and fatigue in patients with Behçet's disease.
28. Tuberculin Skin Test and Quantiferon (R)-TB Gold In-Tube Test for Latent Tuberculosis Before Biologic Treatments: Lower Agreement Rate in Spondyloarthropathies Compared to Rheumatoid Arthritis
29. ASSESSMENT OF PRESENCE, SEVERITY AND RISK FACTORS OF POST- THROMBOTIC SYNDROME IN VASCULAR BEHCET DISEASE: MUTICENTERED RETROSPECTIVE STUDY
30. Self-reported skin severity and quality of life in systemic sclerosis: multicentre validation of PASTUL.
31. Physicians' Biological Drug Preference in Patients With Rheumatoid Arthritis and Spondyloarthritis With a History of Malignancy: Perspectives From the Treasure Database.
32. The Risk of Presarcopenia Is Increased Among Female Patients With Primary Sjögren's Syndrome.
33. The assessment of tocilizumab therapy on recurrent attacks of patients with familial Mediterranean fever: A retrospective study of 15 patients.
34. Damage assessment in adult IgA vasculitis. Cross-sectional results of a multicentre cohort.
35. An investigation of thiol/disulfide homeostasis in patients with Behçet's disease.
36. Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behçet's disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.